Literature DB >> 34950420

Erratum to "Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis".

Chenglin Han1, Zilong Wang1, Shuxiao Chen2, Lin Li3, Yingkun Xu1, Weiting Kang1, Chunxiao Wei4, Hongbin Ma5, Muwen Wang1,4, Xunbo Jin1,4.   

Abstract

[This corrects the article DOI: 10.1155/2021/8851763.].
Copyright © 2021 Chenglin Han et al.

Entities:  

Year:  2021        PMID： 34950420      PMCID： PMC8691978          DOI： 10.1155/2021/9857803

Source DB:  PubMed          Journal:  Oxid Med Cell Longev        ISSN： 1942-0994            Impact factor:   6.543


In the article titled “Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis” [1], the incorrect figure files were used during the production process. The figures should be corrected as follows:
  1 in total

1.  Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis.

Authors:  Chenglin Han; Zilong Wang; Shuxiao Chen; Lin Li; Yingkun Xu; Weiting Kang; Chunxiao Wei; Hongbin Ma; Muwen Wang; Xunbo Jin
Journal:  Oxid Med Cell Longev       Date:  2021-01-13       Impact factor: 6.543
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.